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A B S T R A C T
Aim: Patients with diabetes mellitus (DM) often delay the initiation of insulin treatment and titration
due to psychological factors. This phenomenon is called psychological insulin resistance (PIR). The insulin
treatment appraisal scale (ITAS) that was initially developed for Western populations has been trans-
lated and validated to measure PIR in Taiwanese populations (C-ITAS). This study aims to estimate the
prevalence of PIR in primary care patients with DM in Hong Kong and to examine the relationship between
PIR and psychosocial factors.
Method: 402 DM patients from a government-funded general outpatient clinic completed the C-ITAS and
a health questionnaire (the Patient Health Questionnaire-9, PHQ-9). Patient demographics were re-
corded and associations among C-ITAS scores, PHQ-9 scores and demographic data were evaluated.
Results: There was no relationship between the presence of depression and PIR. Furthermore, the prev-
alence of PIR was 47.2% in insulin-naive patients but only 8.7% in current insulin users. Tools such as the
C-ITAS may help clinicians understand the etiology of PIR, which this study suggests is likely the result
of multiple risk factors. Factors associated with a lower prevalence of PIR included current insulin use,
a family history of insulin use, a high education level, male sex, and having received counseling from a
physician about insulin within the previous 6 months.
© 2015 The Author. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Introduction
Type 2 diabetes mellitus (DM) is a prevalent and increasingly
common disease worldwide [1]. Ten percent of the population of
Hong Kong (HK) (approximately 700,000 people) is estimated to have
DM [2]. Treatment to lower and achieve early good control of
glycosylated hemoglobin (HbA1c) can lead to good long-term HbA1c
control (known as the ‘legacy effect’). Achieving good DM control
early in the disease course can reduce DM-induced microvascular
complications and may reduce macrovascular complications [3,4].
Tight DM control after a long duration of hyperglycemia has not
shown such beneﬁcial results; it may even result in mortality [5–7].
Therefore, achieving early tight HbA1c control through lifestyle
changes and the use of medications, including insulin, is important.
Due to the progressive nature of DM, most patients will even-
tually require insulin [8]. Despite robust evidence of the beneﬁts
of early strict HbA1c control, patients often delay insulin initia-
tion and titration. In a UK study, 50% of DM patients delayed insulin
initiation despite suboptimal control for 5 years, regardless of the
presence of complications [9]. The reluctance to initiate insulin use
[9–11], as well as to its subsequent titration [12], is termed “psy-
chological insulin resistance (PIR)”. The prevalence of PIR was
estimated to be higher in Singapore (70.6%) [10] than in Western
countries (approximately 20–40%) [11]. A questionnaire study in
Hong Kong involving 97 subjects reported a similarly high PIR prev-
alence of 72.1% [13]. Previous studies conducted inWestern countries
have identiﬁed several factors that can lead to PIR [10–12]. However,
the reasons for PIR may differ in Asian countries [14,15]. Recently,
a local primary care research group developed a scale (Ch-ASIQ) to
identify barriers to insulin initiation in insulin-naive DM patients
[15]. These investigators found that Asian patients may be more af-
fected by the availability of social support and that cultural
differences may also play a role. For example, Chinese patients are
more likely to combine Western medical treatments with tradi-
tional Chinese medicine [16], and they may believe that
hypoglycemic agents cause renal toxicity [17].
Depression, a common co-morbid condition among DM pa-
tients, is known to worsen clinical outcomes [18–21]. Depression
has been shown to affect patient decision-making [17]. Behaviors
such as poor drug compliance may be associated with low
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motivation and drive, which are central to the clinical presenta-
tion of depression [20,21]. Alternatively, depressionmay have a direct
biological effect through the stimulation of the sympathetic nervous
system, increasing inﬂammatory and platelet aggregation re-
sponses [21]. In addition, depression has been shown to correlate
with PIR in Western studies with a variance of 3.8% [11] and a cor-
relation factor of 0.2 [19].
This study aimed to estimate the prevalence of PIR in a clinical
setting and to examine the relationship between PIR and psycho-
social factors, including depression.
Methods
The Research Ethics Committee, Kowloon West Cluster, Hospi-
tal Authority approved this research on 25 April 2013.
Participants
Participants were recruited from a government-funded primary
care general outpatient clinic in HK from July to September 2013.
Patients who fulﬁlled the following criteria were recruited: (1) di-
agnosis of type 2 DM as deﬁned by the World Health Organization
[22] for ≥6 months; (2) age of 30 years or over; (3) Chinese eth-
nicity; (4) ability to communicate effectively in Cantonese or
Mandarin; and (5) the mental capacity to provide informed written
consent. The exclusion criteria were severe sensory deﬁcits and
severe mental illnesses (dementia, psychosis and mental retarda-
tion) or any other health conditions that compromised the patient’s
ability to comprehend and complete the questionnaire. Potential sub-
jects were sampled from the clinical appointment database using
a random method.
The required sample size was calculated from the estimated prev-
alence rate of PIR in the primary care setting. With a type I error
set at 0.05, a power set at 0.80, and an estimated 70% prevalence
of PIR among patients with diabetes in public primary care set-
tings [10,13], the required sample size was 312 people. To
compensate for the predicted 20% dropout rate, at least 390 pa-
tients were needed.
Demographic data, including age, sex, marital status, employ-
ment status, education level, family history of insulin use and general
attitudes toward insulin use, were also recorded using a standard-
ized questionnaire. Case records were retrieved for HbA1cmeasures,
the presence of diabetic complications, the presence of treat-
ments for depression and the types of diabetic treatments used (oral
agents and/or insulin).
Patients were encouraged to complete the questionnaires on their
own, as the C-ITAS and PHQ-9 are self-administered instruments.
Because the majority of the patients who attend public primary care
clinics are of lower socio-economic statuses and education levels,
patients who had diﬃculty completing the questionnaires were as-
sisted by research assistants who were trained by the principal
investigator (PI).
Instruments
Insulin Treatment Appraisal Scale (ITAS)
The ITAS is a 20-item instrument that contains 16 negative and
4 positive statements that provide information regarding a patient’s
appraisal of insulin treatment. Each statement is ranked on a 5-point
Likert-type scale. Positive scores are reversed to allow for summa-
tion. The total possible score ranges from 0 to 80. A higher score
indicates a more negative appraisal of insulin. The ITAS was devel-
oped to measure PIR for clinical use [23]. However, there was no
cut-off score for diagnosing PIR.
Patient Health Questionnaire-9 (PHQ-9)
Unlike similar studies that used the Center for Epidemiologic
Studies Depression Scale (CES-D) [11,19], the PHQ-9 was used in the
present study because it is internationally validated and widely used
locally. Furthermore, evidence suggests that higher response rates
can be obtained for shorter questionnaires such as the PHQ-9 [24],
and the PHQ-9 has been used extensively in many research and clin-
ical settings [24,25].
The PHQ-9 questionnaire contains 9 items. Each item is ranked
from 0 (not at all) to 3 (nearly every day), and the total possible score
ranges from 0 to 27 [20]. The original group that developed the scale
suggested cut-off scores of 5, 10, 15, and 20 to represent mild, mod-
erate, moderately severe, and severe depression [20]; at a cutoff score
of 10, the questionnaire exhibits high sensitivity and speciﬁcity values
of approximately 80–90% for identifying depressive disorders, with
reference to the Structured Clinical Interview for DSM-IV [24,25].
Analysis
Patients were classiﬁed as having PIR if they responded ‘strongly
unacceptable’ or ‘unacceptable’ to the question, “Will you agree to
start or titrate insulin treatment if advised by your case doctor?”
Differences in demographic data, clinical data, and scores on the
PHQ-9 and ITAS in patients with andwithout PIRwere detected using
the t-test for continuous variables and the chi-square test for cat-
egorical variables, with a signiﬁcance level set at p < 0.05. Each ITAS
item was dichotomized. The individual ITAS item responses among
patients with and without PIR were compared using the chi-
square test.
Results
Participants
A total of 399 insulin-naive DM patients were randomly se-
lected from the clinical database and approached by the research
team. Forty-two patients were excluded for the following reasons:
2 because they were incorrectly diagnosed with DM; 27 because
they had severely impaired hearing not compensated for with the
use of hearing aids; 3 because they only spoke languages other than
Cantonese and Mandarin; 8 due to known severe psychiatric ill-
nesses, such as dementia, psychosis and mental retardation; 1 due
to leaving at the beginning of the interview when called into the
consultation room; and 1 due to submitting an invalid question-
naire (all of the boxes in the questionnaire were checked).
In addition to insulin-naive DM patients, current insulin users
(47 patients) were invited to participate in this study and were in-
terviewed by phone. In the group of patients who used insulin, three
subjects were excluded for the following reasons: 1 for not being
able to speak Cantonese or Mandarin; 1 who was not in Hong Kong
during the interview period; and 1 whose questionnaire was in-
validated due to a missing entry for the subject’s case number.
The overall response rate was 89.8% (89.6% for the insulin-
naive patients and 90.9% for insulin users). Most respondents had
a household income of less than HKD $10,000 per month (69.1%)
and were elderly (mean 67.7, median 69, range 39–91) and female
(60.8%). Many responders had a household income of less than HKD
$5000 (40.2%). Most responders had up to a primary school level
of education (71%); only 4.9% had an education at the tertiary level
or above, and 23.8% had no formal education. The majority of the
patients were married (67.7%) and retired (76.6%). Fully 45.3% of the
patients had diabetes for more than 10 years; 47.1% had an HbA1c
level lower than 7% (53 mmol/mol), and 16% had an HbA1c level
higher than 8% (63.9mmol/mol). Most patients (59.9%) had LDL levels
of less than 2.7 mmol/L, and 12.0% had LDL levels equal to or higher
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than 3.5mmol/L. Sixteen percent of patients had microalbuminuria,
20% exhibited renal impairment with an estimated glomerular ﬁl-
tration rate of 60 or less using the Modiﬁcation of Diet in Renal
Disease (MDRD) equation, 13.2% had retinopathy that required re-
ferral to an eye specialist, and 4.2% had evidence of diabetic foot
neuropathy with impaired results when tested for vibration. A total
of 12.5% of our subjects were placed on insulin. Patients with HbA1c
>7% (53mmol/mol) (22.3%) were more likely to be on insulin treat-
ment than those with HbA1c <7% (53mmol/mol) (4.1%) (p ≤ 0.001).
HbA1c levels were not signiﬁcantly associated with the presence
of DM complications in the current study.
Non-responders were signiﬁcantly older (mean age 72.32 years
versus 67.17 years, p = 0.0002), were less likely to agree to titrate
insulin (for current insulin users) andwere less educated (91.7% edu-
cated up to the primary level versus 68.9% for responders; p = 0.004).
The differences in other demographic data, including the DM com-
plication rate, insulin use status, marital status, employment status,
family income, and sex, were not statistically signiﬁcant.
Relationship between psychosocial factors and PIR
The PIR prevalence was 47.2% in insulin-naive patients but only
8.7% in current insulin users.
Insulin-naive participants with PIR displayed signiﬁcantly dif-
ferent attitudes toward insulin use. Such participants were more
likely to respond “agree” to the following C-ITAS statements: Q4,
insulin will make others perceive greater sickness (64.8% to 49.3%,
p = 0.013); Q5, insulin will make life less ﬂexible (from 72.5% to
46.4%, p ≤ 0.001); Q6, fear of needle injection (from 84.6% to 54.8%,
p ≤ 0.001); Q7, insulin will increase the risk of hypoglycemia (from
25.4% to 19.7%, p = 0.003); Q9, insulin will cause weight gain (from
19.9% to 11.5%; p = 0.002); Q10, insulin will be diﬃcult to admin-
ister (from 65% to 29.4%, p ≤ 0.001); Q11, insulin means I have to
give up activities that I enjoy (from 39% to 17.4%, p ≤ 0.001); Q12,
insulin means my health will deteriorate (from 46.8% to 31.3%,
p ≤ 0.001); Q13, injecting insulin is embarrassing (from 53.9% to
25.0%; p ≤ 0.001); Q14, injecting insulin is painful (from 68.5% to
42.9%, p ≤ 0.001); Q15, it is diﬃcult to inject insulin correctly every
time (from 75.4% to 43.6%, p ≤ 0.001); and Q16, insulin makes it dif-
ﬁcult to fulﬁll my responsibilities (from 51.4% to 20.9%, p ≤ 0.001).
Conversely, insulin-naive participants with PIR were more likely to
disagree with the following statements: Q3, insulin will improve
my prognosis (29.1 to 72.1%, p ≤ 0.001); Q8, insulin will improve my
health (38.7 to 58.2%, p = 0.001); Q17, insulin helps to maintain good
control of blood glucose (43.7 to 73.5%, p ≤ 0.001); and Q19, insulin
helps to improve my energy levels (28.2 to 35.5%, p = 0.011).
Among insulin-naive subjects, total C-ITAS scores were higher
in those with PIR (from 42.47% to 34.41%, p = 0.005). Current insulin
users exhibited lower total C-ITAS scores than insulin-naive pa-
tients (29.62 to 38.93; p ≤ 0.001).
C-ITAS scores were lower in those who had a family history of
insulin use (33.09 to 38.31, p ≤ 0.001) or who had received coun-
seling from a physician about insulin in the previous 6months (34.13
to 38.2, p = 0.005).
Those who had a family history of insulin use were less likely
to agree with the following statements: Q2, diabetes has gotten
worse (71.7 to 84.4%, p = 0.034); Q6, fear of injecting with a needle
(56.5 to 74.4%, p = 0.012); Q9, causes weight gain (54.3 to 69%,
p = 0.048); and Q15, diﬃculty injecting it correctly each time (47.8
to 71.9%, p = 0.001).
Those who had received a physician’s advice were less likely to
agree with the following statements: Q2, diabetes has gotten worse
(68.1 to 84.7%, p = 0.005); Q4, perceived by others as more sick (58.3
to 72.4%, p = 0.047); Q5, life less ﬂexible (53.2 to 71.8%, p = 0.01);
Q15, diﬃculty injecting it correctly each time (51.1 to 71.2%,
p = 0.006); and Q16, it prevents me from fulﬁlling my responsibili-
ties (p = 31.9 to 57.4%, p = 0.001).
Patients with different sexes, education levels, and DM compli-
cations also displayed signiﬁcant differences in their attitudes toward
insulin use, as presented in Table 1.
Relationship between depression and PIR
Approximately 12% of the participants were screened positive
for depression (i.e., PHQ-9 ≥ 10). More female participants (14.8%
vs. 7.6%; p = 0.032) andmore patients with a past depressive episode
(16.7% vs. 3.7%; p = 0.001) had a PHQ score at or above the cutoff
of 10.
Insulin-naive participants with a positive screen for depres-
sion did not differ in their willingness to start using insulin if
suggested (from 59.5% to 58.3%, p = 0.878). The total C-ITAS scores
of the participants who screened positive for depression did not differ
signiﬁcantly from those who screened negative (from 38 to 37.63;
p = 0.285).
There was no association between the presence of depression
and other psychosocial factors, including the HbA1c level, LDL level,
presence of DM complications, insulin use status, family income,
marital status, employment status, and number of years on insulin.
The published literature suggests that a loss of energy or fatigue
may be associated with PIR [20], but a post-hoc analysis revealed
no association between individual PHQ-9 item scores and the pres-
ence of PIR.
Discussion
In comparison to other published data, in which 30–40% and
25.5–37% [26] of patients attained their HbA1c and LDL targets, re-
spectively, more patients in the public primary care clinic in Hong
Kong achieved satisfactory glycemic control and LDL levels. A similar
control rate has been observed in other government-funded clinics.
In the year 2013, approximately 56% and 56.9% of all DM patients
who received follow-up care in government-funded clinics had
HbA1c levels below 7% (53 mmol/mol) and LDL below 2.7 mmol/
L. The prevalence of depression in DM patients in our study was
similar to the prevalences observed in other studies [27]. Despite
the low education levels among the participants in this study, 89.8%
were able to ﬁnish the C-ITAS questionnaire.
Presence of depression and its relationship with other variables
Although multiple psychosocial reasons for PIR were identi-
ﬁed, depression was not found to be a signiﬁcant factor. There may
be several reasons for this ﬁnding. First, a substantial proportion
of the participants who were screened positive for depression on
the PHQ did not complete the C-ITAS. Further study with a larger
sample size to verify the relationship between depression and PIR
is merited, as there was a higher incompletion rate in this sub-
group in this study. Second, a previous similar study suggested that
the relationship could be weak after adjusting for DM-related psy-
chological distress [19]. In another study, the variance explained by
the model was only 3.8% [11]. A recent study reported no associ-
ation between depression and the delay of insulin initiation [20].
Taking other studies’ results into account, depression does not appear
to display a strong relationship with patients’ psychological resis-
tance to insulin therapy.
The presence of depression was not associated with the pres-
ence of DM complications. This ﬁndingmay be due to our deﬁnitions
of DM complications, which included a glomerular ﬁltration rate
(eGFR) < 60, the presence of microalbuminuria, the presence of reti-
nopathy on retinal photos requiring referral, and possible neuropathy
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Table 1
Relationship of psychosocial factors with reasons for psychological resistance
On insulin Tx? Willing to start insulin
if advised?
Having insulin
using relatives?
Did doctor recommend
to start/titrate insulin?
Yes No p Yes No p Yes No p Yes No p
ITAS total scores Agree or neutral (%) 29.62 38.93 0 34.41 42.47 0.005 33.09 38.31 0 34.13 38.2 0.005
Q2 Diabetes has gotten worse 66 85.2 0.001 71.7 84.4 0.034 68.1 84.7 0.005
Q3 Prevent complications 91.9 83.2 0.012
Q4 Perceived by others as more sick 65.9 78.2 0.012 58.3 72.4 0.047
Q5 Life less ﬂexible 44.7 73.3 0 60.9 83.1 0 53.2 71.8 0.01
Q6 Fear of injection with needle 36.2 77.8 0 62.6 87.4 0 56.5 74.4 0.012
Q7 Risk of hypoglycemia 38.3 75.7 0 64.2 81 0.001
Q8 Improves health 89.1 79.6 0.012
Q9 Causes weight gain 36.2 71.8 0 60.6 77.3 0.001 54.3 69 0.048
Q10 Takes time and energy 19.1 65.3 0 45.9 79.7 0
Q11 Give up activities I enjoy 17 51.1 0 36.1 63.1 0
Q12 My health will deteriorate 31.9 67.2 0 54.4 75.2 0
Q13 Injecting is embarrassing 29.8 51.3 0.006 40 61.7 0
Q14 Injecting is painful 63.5 81.1 0
Q15 Diﬃcult to always inject correctly 27.7 74.9 0 59.1 83.8 0 47.8 71.9 0.001 51.1 71.2 0.006
Q16 Diﬃcult to fulﬁll responsibilities 10.6 61 0 42.3 73.2 0 31.9 57.4 0.001
Q17 Helps to control blood glucose 89.4 75.8 0.038 94.5 83.8 0.001
Q18 Family/friends more concerned 85.8 64.8 0
Q19 Helps to improve energy levels 83.6 70.4 0.003
Q20 More dependent on doctor 46.8 66.8 0.008
Education level less than
or at primary school?
Sex is male? Presence of
microalbuminuria?
(Insulin user) will agree
to titrate insulin?
Yes No p Yes No p Yes No p Yes No p
Q1 Failed on pre-insulin therapy Agree or neutral (%) 84.4 73.4 0.015 85.7 33.3 0.022
Q2 Diabetes has gotten worse 86.9 76.1 0.012
Q11 Give up activities I enjoy 50.4 38.5 0.039 61.4 43.9 0.015
Q13 Injecting is embarrassing 44.9 57 0.036
Q15 Diﬃcult to always inject correctly 72.8 61.5 0.032
Q18 Family/friends more concerned 63.8 80.2 0.006
Q20 More dependent on doctor 74.5 57.2 0.001
HbA1c > 7% >7 year DM? Married? Income < $1000
Yes No p Yes No p Yes No p Yes No p
ITAS total score Agree or neutral (%) 36.83 39.42 0.014
Q2 Diabetes has gotten worse 78.3 86.4 0.043
Q3 Prevent complications 92.1 84.5 0.026
Q4 Perceived by others as more sick 65.2 76.6 0.019
Q9 Causes weight gain 78.6 61.7 0.001
Q11 Give up activities I enjoy 57.3 41.5 0.005 50.2 38.9 0.048
160
K
.P.Lee
/
Journalof
Clinical&
TranslationalEndocrinology
2
(2015)
157–162
with impaired vibration sensation (VPT). These complications did
not signify the presence of symptoms; therefore, patients may have
been unaware of these complications and/or were not distressed
by them.
Psychological insulin resistance and its relationship with
psychosocial variables
Psychological resistance in current insulin users was very low
at 8.7%. This result could either be due to a low PIR at baseline (i.e.,
these patients did not resist the initiation of insulin therapy) or a
genuine drop in resistance after the initiation of insulin therapy, as
suggested in a qualitative study [28]. One longitudinal study in-
volving 44 insulin-naive patients who switched to insulin therapy
reported decreased negative attitudes toward insulin therapy after
insulin was started [29]. The ITAS scores in that study were higher
than the scores in the current study (ITAS mean score of 50), al-
though that study involved a relatively small number of patients.
Therefore, further longitudinal studies may be needed to conﬁrm
the hypothesis that PIR changes over the course of treatment. In our
analysis, insulin users differed signiﬁcantly from insulin-naive pa-
tients in their opinions of insulin (Table 1 attached).
The most common barriers in patients with high psychological
resistance were ‘afraid to inject myself with a needle’ (83.6%), ‘it
is diﬃcult to inject the right amount of insulin correctly at the
right time everyday’ (75.4%) and ‘taking insulin makes life less
ﬂexible’ (72.5%), in contrast to what doctors may commonly
assume is the predominant fear (i.e., ‘injecting insulin is painful’
(68.5%)).
Patients who had received the advice of a physician regarding
starting or titrating insulin exhibited lower total C-ITAS scores. The
patients who received a physician’s advice may have had a clearer
understanding of insulin initiation and were thus less concerned
about injection techniques, diﬃculty in undertaking the task or the
implication that they were sicker. These results suggest that advice
from physicians is effective in reducing psychological resistance. The
importance of counseling was also reﬂected by the fact that pa-
tients with a lower education level (at or below the primary school
level) were more likely to believe that insulin was diﬃcult to ad-
minister, painful and embarrassing, and they were more anxious
about self-injections.
A family history of insulin usewas protective against PIR (Table 1),
whichmay be due to the low incidence of complications among rela-
tives (12.5%). However, the PIR rate between those who had relatives
with and without complications while on insulin was not statisti-
cally signiﬁcant (p = 0.713). As previously mentioned, patients may
indirectly learn from the experiences of relatives and thus have a
clearer understanding of the nature of insulin use, which suggests
that positive role models can inﬂuence PIR.
The above ﬁnding suggests that participants’ opinions of insulin
use are strongly inﬂuenced by social interactions, such as those with
their doctors and families, perhaps even more than the actual se-
verity of the disease and the presence of complications. Counseling
strategies have been suggested [30,31], but further study may be
needed to identify which counseling elements effectively amelio-
rate PIR. The importance of social interactions or family support was
also identiﬁed by another study conducted in Hong Kong [15] that
suggested a correlation between perceived family support and health
behaviors in Chinese patients. To the author’s knowledge, no study
has yet been conducted to evaluate the effects of interventions, such
as counseling, on ITAS scores or to use ITAS scores to detect reasons
for PIR. However, such studies are feasible because the ITAS ques-
tionnaire was designed to detect changes in a patient’s perception
of insulin treatment [23].
As social interactions had signiﬁcant effects on PIR, effects of
advice from friends, other health professionals (e.g., nursing staff),
and patient support groups can be examined in future research.
Comparison of ITAS scores with those from other studies
An interesting observation in the current studywas that themean
total C-ITAS score in insulin-naive patients was generally lower
(38.9%) than the scores obtained in other studies, which range from
50 [28] to 62.9 [14]. This is in contrast with the fact that, as men-
tioned previously, there is a higher prevalence of PIR in the local
community. Further studies may be needed to re-examine the va-
lidity of the Chinese ITAS questionnaire and to seek an explanation
for this observation.
Strengths and weaknesses
The strengths of our study include the relatively large sample
size, the use of random sampling and the very high response rate.
To the author’s knowledge, this is the ﬁrst local study using an in-
ternationally validated questionnaire (the ITAS) to examine the
relationship between depression and PIR in the primary care setting.
The results of this study supporting the proposed use of insulin
in patients are tentative. For example, the estimated psychologi-
cal resistance rate may have decreased because patients perceived
that their condition had deteriorated and that further interven-
tion was needed.
Although this study was conducted in a major government-
funded clinic in Hong Kong, the demographics of the participants
were similar to those of other government clinics (Fig. 1), and the
results of the current study are largely comparable to similar studies
conducted in Istanbul [19] and Amsterdam [11], the extent to which
the results can be generalized to other countries and to other social
classes (e.g., wealthy patients attending private primary clinics) is
not known.
Figure 1. Comparison of demographic data.
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Conclusion
Depression was identiﬁed as a common co-morbid condition of
DM. Multiple psychosocial dimensions were associated with
PIR, but depression was not. These results suggest that PIR is
inﬂuenced by numerous factors, including information, adequate
counseling and positive role models, such as family members.
This study suggested that the ITAS is a valid tool for understand-
ing reasons underlying patients’ PIR, and it could, therefore, help
doctors provide speciﬁc and patient-centered counseling. In the
Chinese population, psychosocial factors, rather than presence of
complications, may play a more important role in determining PIR.
This suggests that certain interventions (e.g., patient support groups)
may be more effective in this population.
Further study may be needed to ﬁnd ways to ameliorate PIR and
to see if PIR changes over the course of DM treatments.
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